DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Dow Jones - 17 AbbVie - 1 Brian L - 1 Frank - 1 ImmunoGen - 1 wolfgang rattay - 1 Bayer - 1 JENNIFER LORENZINI - 1
Top related locs:
U.S
Top related orgs:
pfizer - 5 pharma - 2 fda - 2 The Wall Street Journal - 1 Bayer - 1 Food and Drug Administration - 1 CVS Health - 1 sanofi - 1

Search resuls for: "Jared S. Hopkins"


25 mentions found


☆ AbbVie to Buy Cancer Biotech ImmunoGen for More Than $10 Billion
  + stars: | 2023-11-30 | by ( Jared S. Hopkins | Colin Kellaher | ) www.wsj.com   time to read: 1 min
If the deal goes through, AbbVie would acquire ImmunoGen’s flagship cancer therapy Elahere. Photo: Brian L. Frank for The Wall Street JournalDrug company AbbVie has agreed to buy biotech ImmunoGen for $10.1 billion in a new bet on one of the most promising novel drug technologies for attacking cancer. ImmunoGen develops cancer drugs called antibody-drug conjugates, or ADCs, which work like guided missiles delivering a toxic agent directly to tumors. The technology is among the hottest areas in the pharmaceutical industry. Recent advancements have spread its use to common kinds of cancer such as breast, spawning other multibillion-dollar deals.
Persons: AbbVie, Brian L, Frank, ImmunoGen Organizations: The Wall Street Journal
☆ How Your Dog or Cat Could Help Speed Up Your Health Tests
  + stars: | 2023-11-27 | by ( Jared S. Hopkins | Photographs Tayler Smith For The Wall Street Journal | ) www.wsj.com   time to read: 1 min
Imagine getting medical-test results within minutes or seconds, before you leave the doctor’s office, for even the most complicated diagnoses. Steps toward that goal are happening in an unlikely place: The veterinarian’s office. Researchers are using results from your pets’ tests for things like hookworms and other parasites to train artificial intelligence tools that not only speed up Fido’s results, but are informing human diagnostics, too.
☆ Bayer Shares Tumble After Clinical Trial Failure, Loss in Roundup Case
  + stars: | 2023-11-20 | by ( Adrià Calatayud | Jared S. Hopkins | ) www.wsj.com   time to read: 1 min
Bayer’s court loss on its Roundup weedkiller was the fourth decision in a row to go against the company. Photo: wolfgang rattay/ReutersBayer shares fell sharply after the company stopped a late-stage study for a blood-thinning drug early because of lack of efficacy and was told to pay $1.56 billion in a lawsuit relating to its Roundup weedkiller. Bayer said late Sunday that it discontinued a Phase 3 clinical trial to test its experimental drug asundexian for prevention of stroke and systemic embolism for patients with the heart-rhythm disorder atrial fibrillation.
Persons: wolfgang rattay, Bayer Organizations: Bayer
☆ Same Drug, Two Prices: Why the Higher Price Prevails
  + stars: | 2023-11-08 | by ( Peter Loftus | Jared S. Hopkins | ) www.wsj.com   time to read: 1 min
The way medicines are paid for in the U.S. has become so convoluted that some drugmakers are setting two prices for the same drug—and many health plans are choosing to cover the more expensive version. The decisions mean some patients are paying hundreds of dollars more in out-of-pocket charges to fill a prescription for an identical medicine made by the same company.
Locations: U.S
☆ Same Drug, Two Prices: Why The Higher Price Prevails
  + stars: | 2023-11-08 | by ( Peter Loftus | Jared S. Hopkins | ) www.wsj.com   time to read: 1 min
The way medicines are paid for in the U.S. has become so convoluted that some drugmakers are setting two prices for the same drug—and many health plans are choosing to cover the more expensive version. The decisions mean some patients are paying hundreds of dollars more in out-of-pocket charges to fill a prescription for an identical medicine made by the same company.
Locations: U.S
☆ If Some Cold Medicines Don’t Work, What Should You Take for a Stuffy Nose?
  + stars: | 2023-10-30 | by ( Jared S. Hopkins | ) www.wsj.com   time to read: 1 min
When a cold or flu strikes, choosing among hundreds of products can be overwhelming. But to clear up a stuffy nose, doctors and pharmacists say consumers should choose medicine wisely. A key ingredient found in many over-the-counter medicines—oral phenylephrine—just doesn’t work, according to a finding last month by advisers to the Food and Drug Administration. A few weeks after that determination, CVS Health stopped selling certain oral medicines with the ingredient.
Organizations: Food and Drug Administration, CVS Health
☆ Why Drug Companies Don’t Want to Sell Allergy Medicines and Bandages Anymore
  + stars: | 2023-10-27 | by ( Jared S. Hopkins | Adrià Calatayud | ) www.wsj.com   time to read: 1 min
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com. https://www.wsj.com/health/healthcare/sanofi-plans-to-spin-off-consumer-healthcare-business-ab808c6f
Persons: Dow Jones Organizations: sanofi
☆ Pfizer Prices Covid Drug Paxlovid at $1,400 for a Five-Day Course
  + stars: | 2023-10-19 | by ( Jonathan D. Rockoff | Jared S. Hopkins | ) www.wsj.com   time to read: 1 min
Pfizer has already faced criticism that raising the price of Paxlovid will limit patient access. Photo: JENNIFER LORENZINI/REUTERSPfizer will price a course of its Covid-19 drug Paxlovid at nearly $1,400 when commercial sales begin later this year, more than double what the U.S. government has paid. Pfizer told the pharmacies and clinics that will dispense Paxlovid, in a letter dated Wednesday that was viewed by The Wall Street Journal, that a five-day course of the antiviral will list for $1,390. The U.S. government had paid $529.
Persons: JENNIFER LORENZINI Organizations: Pfizer, REUTERS Pfizer, Wall Street Journal Locations: U.S
☆ CVS Pulls Certain Cold Medicines From Shelves and Will Stop Selling Them
  + stars: | 2023-10-19 | by ( Jared S. Hopkins | ) www.wsj.com   time to read: 1 min
CVS operates more than 9,000 retail locations and 1,100 walk-in clinics nationwide. Photo: Ted Shaffrey/Associated PressCVS Health is pulling some of the most common decongestants from its shelves and will no longer sell them, after advisers to U.S. health regulators recently determined that an ingredient doesn’t work. The products contain oral phenylephrine, an almost-century-old ingredient in versions of decongestants and over-the-counter pills, syrups and liquids to clear up congested noses.
Persons: Ted Shaffrey Organizations: CVS, Press CVS Health
☆ The Brash Strategy That Made Vivek Ramaswamy a Fortune
  + stars: | 2023-09-09 | by ( Peter Rudegeair | Jared S. Hopkins | John Mccormick | ) www.wsj.com   time to read: 1 min
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com. https://www.wsj.com/politics/elections/the-brash-strategy-that-made-vivek-ramaswamy-a-fortune-ef6b8cdb
Persons: Dow Jones, ramaswamy
☆ How Novartis’s CEO Learned From His Mistakes and Got Help From an Unlikely Quarter
  + stars: | 2023-09-03 | by ( Jared S. Hopkins | ) www.wsj.com   time to read: 1 min
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com. https://www.wsj.com/health/pharma/how-novartiss-ceo-learned-from-his-mistakes-and-got-help-from-an-unlikely-quarter-b087ebbb
Persons: Dow Jones Organizations: pharma
☆ Expensive Drugs From Pfizer, Other Companies Targeted for First U.S. Price Negotiations
  + stars: | 2023-08-29 | by ( Jared S. Hopkins | Stephanie Armour | ) www.wsj.com   time to read: 1 min
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com. https://www.wsj.com/health/pharma/expensive-drugs-from-pfizer-other-companies-targeted-for-first-u-s-price-negotiations-9942b20b
Persons: Dow Jones Organizations: pfizer
☆ Expensive Drugs Targeted for First U.S. Price Negotiations
  + stars: | 2023-08-29 | by ( Jared S. Hopkins | Stephanie Armour | ) www.wsj.com   time to read: 1 min
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com. https://www.wsj.com/health/pharma/expensive-drugs-from-pfizer-other-companies-targeted-for-first-u-s-price-negotiations-9942b20b
Persons: Dow Jones Organizations: pfizer
☆ FDA Approves RSV Vaccine to Pass Protection From Mother to Child
  + stars: | 2023-08-21 | by ( Jared S. Hopkins | ) www.wsj.com   time to read: 1 min
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com. https://www.wsj.com/health/pharma/rsv-vaccine-fda-pfizer-mother-child-bf7aaf24
Persons: Dow Jones, bf7aaf24 Organizations: pharma, fda, pfizer
☆ He Was a Scientist. Could He Find a Drug to Treat His Own Disease?
  + stars: | 2023-08-13 | by ( Jared S. Hopkins | Photographs Hannah Beier For The Wall Street Journal | ) www.wsj.com   time to read: 1 min
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com. https://www.wsj.com/articles/he-was-a-scientist-could-he-find-a-drug-to-treat-his-own-disease-c6839236
Persons: Dow Jones
☆ A New Omicron Subvariant, Dubbed ‘Eris,’ Heralds Covid-19’s Resurgence
  + stars: | 2023-08-10 | by ( Brianna Abbott | Jon Kamp | Jared S. Hopkins | ) www.wsj.com   time to read: 1 min
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com. https://www.wsj.com/articles/eg5-eris-new-covid-19-variant-fa3cc260
Persons: Dow Jones
☆ Drug Shortages Are a Boon to One Industry: Compounding Pharmacies
  + stars: | 2023-08-07 | by ( Jared S. Hopkins | Liz Essley Whyte | ) www.wsj.com   time to read: 1 min
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com. https://www.wsj.com/articles/drug-shortages-compounding-pharmacies-medicine-bae67d98
Persons: Dow Jones
☆ Pfizer’s Covid Boost Crashes to Earth
  + stars: | 2023-08-06 | by ( Jared S. Hopkins | ) www.wsj.com   time to read: 1 min
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com. https://www.wsj.com/articles/pfizers-covid-boost-crashes-to-earth-51e1d0
Persons: Dow Jones
☆ Pfizer Misses Revenue Expectations, Bets on Drug Launches to Ease Shortfall
  + stars: | 2023-08-01 | by ( Jared S. Hopkins | ) www.wsj.com   time to read: 1 min
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com. https://www.wsj.com/articles/pfizer-misses-expectations-but-bets-on-new-drug-launches-to-ease-shortfall-f1d3f3c8
Persons: Dow Jones Organizations: pfizer
☆ Tornado Damages Key Pfizer Drugmaking Plant
  + stars: | 2023-07-20 | by ( Jared S. Hopkins | ) www.wsj.com   time to read: 1 min
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com. https://www.wsj.com/articles/tornado-damages-key-pfizer-drugmaking-plant-64024e7
Persons: Dow Jones Organizations: pfizer
☆ FDA Approves First RSV Drug to Protect All Infants From Virus
  + stars: | 2023-07-17 | by ( Jared S. Hopkins | ) www.wsj.com   time to read: 1 min
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com. https://www.wsj.com/articles/fda-approves-first-rsv-drug-to-protect-all-infants-from-virus-52907caf
Persons: Dow Jones Organizations: fda
☆ Drugs Like Ozempic Created a Gold Rush. These Drugmakers Want In.
  + stars: | 2023-07-16 | by ( Jared S. Hopkins | ) www.wsj.com   time to read: 1 min
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com. https://www.wsj.com/articles/weight-loss-drug-ozempic-gold-rush-baf849bd
Persons: Dow Jones
☆ Eli Lilly Is Buying Another Potential Obesity Treatment in Deal Worth Up to $2 Billion
  + stars: | 2023-07-14 | by ( Ben Glickman | Jared S. Hopkins | ) www.wsj.com   time to read: 1 min
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com. https://www.wsj.com/articles/eli-lilly-to-acquire-obesity-treatment-maker-versanis-5d92c56d
Persons: Dow Jones, eli, lilly
☆ Bausch + Lomb’s CEO Inks First Big Deal Since Return
  + stars: | 2023-06-30 | by ( Jared S. Hopkins | ) www.wsj.com   time to read: 1 min
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com. https://www.wsj.com/articles/bausch-lombs-ceo-inks-first-big-deal-since-return-5f2ec13
Persons: Dow Jones Organizations: lombs
☆ New $2.9 Million Gene Therapy Promises to Remake Hemophilia Treatment
  + stars: | 2023-06-30 | by ( Jared S. Hopkins | ) www.wsj.com   time to read: 1 min
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com. https://www.wsj.com/articles/new-2-9-million-gene-therapy-promises-to-remake-hemophilia-treatment-da254ef4
Persons: Dow Jones
0 next >>
Total: 25